Scarica l'app Stockscreener
139.71
0.17%
0.24
Dopo l'orario di chiusura:
139.71
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$139.47
Aprire:
$139.07
Volume 24 ore:
442.89K
Relative Volume:
1.10
Capitalizzazione di mercato:
$9.20B
Reddito:
$3.55B
Utile/perdita netta:
$370.24M
Rapporto P/E:
25.49
EPS:
5.48
Flusso di cassa netto:
$355.96M
1 W Prestazione:
+0.09%
1M Prestazione:
-13.22%
6M Prestazione:
-4.73%
1 anno Prestazione:
-6.96%
Intervallo 1D:
$138.01
$140.16
Intervallo di 1 settimana:
$138.01
$143.33
Portata 52W:
$130.85
$178.03
Aptargroup Inc Stock (ATR) Company Profile
Nome
Aptargroup Inc
Settore
Industria
Telefono
(815) 477-0424
Indirizzo
265 EXCHANGE DRIVE, CRYSTAL LAKE, IL
Confronta ATR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATR
Aptargroup Inc
|
139.71 | 9.08B | 3.55B | 370.24M | 355.96M | 5.48 |
|
ISRG
Intuitive Surgical Inc
|
474.26 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
194.07 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
81.45 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
285.17 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
244.50 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Aptargroup Inc Stock (ATR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-07 | Iniziato | Raymond James | Outperform |
| 2025-01-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-10-14 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-04-29 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-01-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-08-02 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-04-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-10-14 | Iniziato | Seaport Global Securities | Neutral |
| 2020-04-27 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-03-25 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2020-03-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-02-26 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-07-08 | Iniziato | Morgan Stanley | Overweight |
| 2019-04-05 | Reiterato | BofA/Merrill | Underperform |
| 2019-02-27 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-05-18 | Iniziato | Jefferies | Hold |
| 2016-12-07 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2016-10-13 | Iniziato | Jefferies | Hold |
| 2016-01-05 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2015-11-02 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2015-09-15 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2015-05-01 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
| 2013-02-19 | Reiterato | Deutsche Bank | Hold |
| 2013-01-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2012-07-10 | Downgrade | KeyBanc Capital Mkts | Buy → Hold |
| 2012-04-11 | Iniziato | KeyBanc Capital Mkts | Buy |
| 2011-06-13 | Aggiornamento | KeyBanc Capital Mkts | Hold → Buy |
Mostra tutto
Aptargroup Inc Borsa (ATR) Ultime notizie
AptarGroup Inc. Approaches Psychological Resistance Level2025 Trade Ideas & Long-Term Growth Portfolio Plans - thegnnews.com
Is There An Opportunity With AptarGroup, Inc.'s (NYSE:ATR) 37% Undervaluation? - Yahoo Finance
RSI + MACD Show Convergence for AptarGroup Inc.Weekly Market Summary & Verified Short-Term Plans - beatles.ru
Is AptarGroup Inc. gaining market shareInflation Watch & Free Growth Oriented Trading Recommendations - newsyoung.net
Published on: 2025-08-16 12:25:29 - metal.it
Aptargroup's 15min Chart Indicates Bearish Trends with KDJ Death Cross and Marubozu. - AInvest
AptarGroup: Resilience in Core Pharma Segment & Critical Growth Levers! - Smartkarma
Is AptarGroup, Inc. (NYSE:ATR) Trading At A 36% Discount? - 富途牛牛
AptarGroup (ATR) Gets Buy Rating from Blair, Supported by Attractive Valuation - MSN
Pharmaceutical Packaging Market Trends and Company Analysis - GlobeNewswire
Pharmaceutical Packaging Market Trends and Company Analysis Report 2025-2033 Featuring Amcor, 3M, Schott, WestRock, Berry Global, McKesson, AptarGroup, Klockner Pentaplast, CCL, FlexiTuff - Yahoo Finance
13 Best Defensive Stocks to Invest in According to Analysts - Insider Monkey
5 Dividend Aristocrats with Capital Gains Potential - AInvest
AptarGroup (NYSE:ATR) sheds 12% this week, as yearly returns fall more in line with earnings growth - simplywall.st
AptarGroup Inc Reports Strong Q2 2025 Earnings Despite Challenges - AInvest
AptarGroup Reports Strong Q2 2025 Results - TipRanks
AptarGroup Price Target Cut to $172 by Raymond James, Maintains Outperform Rating - AInvest
Analysts' Opinions on Bausch + Lomb Corporation, Avantor, and AptarGroup: A Mixed Bag - AInvest
Aptar Earnings: Growth Resumes As Beauty and Closures Rebound - Morningstar
AptarGroup expects Q3 adjusted EPS of $1.53–$1.61 while navigating inventory headwinds and litigation costs - MSN
What makes AptarGroup Inc. stock price move sharplyBuild your wealth with consistent stock growth - Jammu Links News
Is it the right time to buy AptarGroup Inc. stockBuild a portfolio that stands the test of time - Jammu Links News
When is AptarGroup Inc. stock expected to show significant growthBreakout stock performance - Jammu Links News
Is AptarGroup Inc. stock overvalued or undervaluedCapitalize on emerging investment opportunities - Jammu Links News
How strong is AptarGroup Inc. company’s balance sheetExtraordinary market timing - Jammu Links News
What are the latest earnings results for AptarGroup Inc.Get daily updates on market movers and shakers - Jammu Links News
Does AptarGroup Inc. stock perform well during market downturnsExceptional return forecasts - Jammu Links News
What catalysts could drive AptarGroup Inc. stock higher in 2025Jaw-dropping returns - Jammu Links News
AptarGroup's 2025 Q2 Earnings and Strategic Positioning: Navigating Supply Chain Shifts While Delivering Sustainable Growth - AInvest
AptarGroup, Inc. (NYSE:ATR) Q2 2025 Earnings Call Transcript - Insider Monkey
AptarGroup's Q3 Earnings Outlook: Navigating Legal and Market Headwinds While Maintaining Growth Momentum - AInvest
AptarGroup Inc (ATR) Q2 2025 Earnings Call Highlights: Strong Growth and Strategic Expansions ... - Yahoo Finance
AptarGroup (ATR): Navigating Short-Term Headwinds to Unlock Long-Term Growth in Pharma Innovation - AInvest
AptarGroup Inc (ATR) Q2 2025 Earnings Call Highlights: Strong Growth and Strategic Expansions ... By GuruFocus - Investing.com Canada
SWK Holdings Finalizes Asset Sale to AptarGroup - MSN
AptarGroup Earnings Call: Pharma and Closures Shine - TipRanks
AptarGroup (ATR) Q2 Revenue Rises 6% - The Motley Fool
AptarGroup's Q2 2025: Unpacking Contradictions in Pharma Growth, Legal Costs, and Beauty Segment Challenges - AInvest
Research Alert: Aptargroup Posts 15th Consecutive Eps Beat With Accelerating Margin Expansion - 富途牛牛
What is AptarGroup Inc. company’s growth strategySmart Portfolio Recommendation For Beginners - jammulinksnews.com
Relative Strength Alert For AptarGroup - Nasdaq
AptarGroup Q2 2025 Earnings Preview - MSN
Aptar Launches Bio-based Nasal Spray Packaging Solution - PlasticsToday
APTARGROUP, INC. SEC 10-Q Report - TradingView
Earnings call transcript: AptarGroup Q2 2025 beats EPS forecast, shares dip By Investing.com - Investing.com South Africa
Earnings call transcript: AptarGroup Q2 2025 beats EPS forecast, shares dip - Investing.com Australia
What are the technical indicators suggesting about AptarGroup Inc.Stock Strategy Trend Scanner To Watch Now - Jammu Links News
Why AptarGroup (ATR) is a Top Growth Stock for the Long-Term - Yahoo Finance
How does AptarGroup Inc. compare to its industry peersExpert Picks Data Feed From AI Tools - Jammu Links News
AptarGroup Surpasses Q2 Earnings Forecasts with Strong PerformanceNews and Statistics - IndexBox
AptarGroup Lifts Sales And Profit On Pharma Demand In Q2 - Finimize
Aptargroup Inc Azioni (ATR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.19%
0.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):